Cancer research meets tick vectors for infectious diseases

The Lancet Infectious Diseases

Volumn 14, Issue 10, 2014, Pages 916-917

  Cabezas Cruz, Alejandro ^a,b   Valdés, James ^c   De la Fuente, José ^b,d  

^a UNIV LILLE   (France)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c INSTITUTE OF PARASITOLOGY   (Czech Republic)

^d OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GAL; CARBOHYDRATE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; PARASITE ANTIGEN; SNAKE VENOM; UNCLASSIFIED DRUG; VACCINE; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY;

AMBLYOMMA AMERICANUM; ANAPHYLAXIS; BASOPHIL; BIOLOGICAL FUNCTIONS; CANCER RESEARCH; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; HAEMAPHYSALIS LONGICORNIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; IXODES RICINUS; MAST CELL; METASTATIC COLORECTAL CANCER; NOTE; PARASITE VECTOR; PROTEIN FAMILY; PRURITUS; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; TH2 CELL; TICK; TICK BITE; TICK INFESTATION; TOXIC ORGANISM; ANIMAL; BLOOD; IMMUNOLOGY; NEOPLASMS; TICK BORNE DISEASE; UNITED STATES;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; ARACHNID VECTORS; HUMANS; IMMUNOGLOBULIN E; NEOPLASMS; TICK INFESTATIONS; TICK-BORNE DISEASES; TICKS; UNITED STATES;

EID: 84908126648     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70902-8     Document Type: Note

References (16)

1. O'Neil B, Allen R, Spigel D, et al. High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history. J Clin Oncol 2007, 25:3644-3648.
2. Platts-Mills T, Commins S Emerging antigens involved in allergic responses. Curr Opin Immunol 2013, 25:769-774.
3. Chung CH, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 2008, 358:1109-1117.
4. Lammerts van Bueren J, Rispens T, Verploegen S, et al. Anti-galactose-α-1,3-galactose IgE from allergic patients does not bind α-galactosylated glycans on intact therapeutic antibody Fc domains. Nat Biotechnol 2011, 29:574-576.
5. Commins S, James H, Kelly L, et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose. J Allergy Clin Immunol 2011, 127:1286-1293.
6. Commins S, Platts-Mills T Tick bites and red meat allergy. Curr Opin Allergy Clin Immunol 2013, 13:354-359.
7. Wikel S Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment. Front Microbiol 2013, 19:337-346.
8. Kashino S, Resende J, Sacco A, et al. Boophilus microplus: the pattern of bovine immunoglobulin isotype responses to high and low tick infestations. Exp Parasitol 2005, 110:12-21.
9. Christe M, Rutti B, Brossard M Susceptibility of BALB/c mice to nymphs and larvae of Ixodes ricinus after modulation of IgE production with anti-interleukin-4 or anti-interferon-gamma monoclonal antibodies. Parasitol Res 1998, 84:388-393.
10. Ushio H, Watanabe N, Kiso Y, Higuchi S, Matsuda H Protective immunity and mast cell and eosinophil responses in mice infested with larval Haemaphysalis longicornis ticks. Parasite Immunol 1993, 15:209-214.
11. Wada T, Ishiwata K, Koseki H, et al. Selective ablation of basophils in mice reveals their non-redundant role in acquired immunity against ticks. J Clin Invest 2010, 120:2867-2875.
12. Brown S, Galli S, Gleich G, Askenase P Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol 1982, 129:790-796.
13. Nakahigashi K, Otsuka A, Tomari K, Miyachi Y, Kabashima K Evaluation of basophil infiltration into the skin lesions of tick bites. Case Rep Dermatol 2013, 5:48-51.
14. Fry B, Roelants K, Champagne D, et al. The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet 2009, 10:483-511.
15. Palm N, Rosenstein R, Yu S, Schenten D, Florsheim E, Medzhitov R Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 2013, 39:976-985.
16. Marichal T, Starkl P, Reber L, et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 2013, 39:963-975.